Sanofi ADR/ US80105N1054 /
13/11/2024 21:59:58 | Chg. -0.63 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
49.52USD | -1.26% | 114,912 Turnover: 5.68 mill. |
-Bid Size: - | -Ask Size: - | 125.3 bill.USD | - | - |
Assets
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 9,651 | 9,717 | 9,365 | 10,028 | 9,869 | ||||||
Intangible Assets | 21,889 | 16,572 | 18,421 | 21,407 | 21,640 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | 82,148 | 83,800 | 80,743 | 89,589 | 92,611 | ||||||
Inventories | 7,477 | 7,994 | 8,352 | 8,715 | 8,960 | ||||||
Accounts Receivable | 7,260 | 7,937 | 7,491 | 7,568 | 8,424 | ||||||
Cash and Cash Equivalents | 6,925 | 9,427 | 13,915 | 10,098 | 12,736 | ||||||
Current Assets | 24,579 | 28,611 | 33,703 | 30,564 | 34,026 | ||||||
Total Assets | 111,408 | 112,736 | 114,529 | 120,242 | 126,722 |
Liabilities
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 5,041 | 5,313 | 5,295 | 6,180 | 6,813 | ||||||
Long-term debt | - | - | - | - | 16,761 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | 2,294 | 1,770 | 1,617 | 20,203 | ||||||
Liabilities | 52,373 | 53,628 | 51,382 | 51,211 | 51,560 | ||||||
Share Capital | 2,495 | 2,508 | 2,518 | 2,527 | - | ||||||
Total Equity | 58,876 | 58,934 | 63,001 | 68,681 | 74,784 | ||||||
Minority Interests | 159 | 174 | 146 | 350 | 368 | ||||||
Total liabilities equity | 111,408 | 112,736 | 114,529 | 120,242 | 126,722 |
Income Statement
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 34,463 | 36,126 | 36,041 | 37,761 | 42,997 | ||||||
Depreciation (total) | 2,170 | 2,146 | 1,681 | 1,580 | 2,053 | ||||||
Operating Result | 4,676 | 3,125 | 14,141 | 8,126 | 10,656 | ||||||
Interest Income | -271 | -303 | -337 | -328 | -234 | ||||||
Income Before Taxes | 4,405 | 2,822 | 13,804 | 7,798 | 10,422 | ||||||
Income Taxes | 481 | 139 | 1,813 | 1,558 | 2,006 | ||||||
Minority Interests Profit | -104 | -31 | -36 | -56 | -113 | ||||||
Net Income | 4,306 | 2,806 | 12,314 | 6,223 | 8,371 |
Per Share
Cash Flow
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 5,547 | 7,744 | 7,449 | 10,522 | 10,526 | ||||||
Cash Flow from Investing Activities | -12,866 | -1,212 | 3,588 | -7,298 | -2,075 | ||||||
Cash Flow from Financing | 3,934 | -4,193 | -6,485 | -7,056 | -5,821 | ||||||
Decrease / Increase in Cash | -3,390 | 2,502 | 4,488 | -3,817 | - | ||||||
Employees | 104,226 | 100,409 | 99,412 | 95,442 | 91,573 |